Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A N Giagounidis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Leukemia Research|March 24, 2009
Myelodysplasia or myelodysplastic syndrome?A A N Giagounidis
Annals of Hematology|August 19, 2004
Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenesA A N Giagounidis, M Heinsch, S Haase, et al.
Annals of Hematology|June 18, 2003
Fournier's gangreneA A N Giagounidis, M Heinsch, R Kasperk, et al.
Acta Haematologica|April 2, 2005
Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletionA A N Giagounidis, S Haase, U Germing, et al.
Hematology (Amsterdam, Netherlands)|December 29, 2004
The 5q- syndromeA A N Giagounidis, U Germing, J S Wainscoat, et al.
Annals of Hematology|May 14, 2005
Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroupA A N Giagounidis, U Germing, C Strupp, et al.
Annals of Hematology|March 22, 2002
Testicular infiltration in acute myeloid leukemia with complex karyotype including t(8;21)A A N Giagounidis, B Hildebrandt, S Braunstein, et al.
Leukemia|August 27, 2010
Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q)C Chen, D T Bowen, A A N Giagounidis, et al.
European Journal of Haematology|October 9, 2002
Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot studyA A N Giagounidis, J Anhuf, P Schneider, et al.
Leukemia|October 31, 2003
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31A A N Giagounidis, U Germing, S Haase, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Leukemia Research|March 24, 2009
Myelodysplasia or myelodysplastic syndrome?A A N Giagounidis
Annals of Hematology|August 19, 2004
Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenesA A N Giagounidis, M Heinsch, S Haase, et al.
Annals of Hematology|June 18, 2003
Fournier's gangreneA A N Giagounidis, M Heinsch, R Kasperk, et al.
Acta Haematologica|April 2, 2005
Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletionA A N Giagounidis, S Haase, U Germing, et al.
Hematology (Amsterdam, Netherlands)|December 29, 2004
The 5q- syndromeA A N Giagounidis, U Germing, J S Wainscoat, et al.
Annals of Hematology|May 14, 2005
Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroupA A N Giagounidis, U Germing, C Strupp, et al.
Annals of Hematology|March 22, 2002
Testicular infiltration in acute myeloid leukemia with complex karyotype including t(8;21)A A N Giagounidis, B Hildebrandt, S Braunstein, et al.
Leukemia|August 27, 2010
Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q)C Chen, D T Bowen, A A N Giagounidis, et al.
European Journal of Haematology|October 9, 2002
Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot studyA A N Giagounidis, J Anhuf, P Schneider, et al.
Leukemia|October 31, 2003
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31A A N Giagounidis, U Germing, S Haase, et al.
Pageof 2